Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Stibbe

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Thrombosis and Haemostasis|February 1, 1996
Phenotyping and genotyping of coagulation factor V LeidenH Engel, L Zwang, H H van Vliet, et al.
The Netherlands Journal of Medicine|March 1, 1995
Heparin-induced thrombocytopenia and thrombosis: a potential fatal complication in a routine treatmentD M Boon, M C Kappers-Klunne, J J Michiels, et al.
Lancet (London, England)|November 5, 1994
Heparin-induced thrombocytopenia and antithrombotic therapyD M Boon, J J Michiels, J Stibbe, et al.
Nederlands Tijdschrift Voor Geneeskunde|April 16, 1994
[The HITT syndrome: thrombocytopenia and thrombosis induced by heparin as cause of paradoxically-occurring thromboembolisms]D M Boon, M C Kappers-Klunne, J J Michiels, et al.
Thrombosis Et Diathesis Haemorrhagica|September 30, 1975
Letter: A method for assaying von Willebrand factor (ristocetin cofactor)D E Macfarlane, J Stibbe, E P Kirby, et al.
Transplantation Proceedings|October 1, 1990
Fibrinolysis in auxiliary partial liver transplantationC M Bakker, R J Porte, E A Knot, et al.
Postgraduate Medical Journal|December 1, 1994
High-dose intravenous gammaglobulin therapy for acquired von Willebrand diseaseP J Van Genderen, D N Papatsonis, J J Michiels, et al.
British Journal of Haematology|August 1, 1990
Haemophilia protects against ischaemic heart disease: a study of risk factorsF R Rosendaal, E Briët, J Stibbe, et al.
British Journal of Haematology|February 13, 2001
Two novel and one recurrent missense mutation in the factor XIII A gene in two Dutch patients with factor XIII deficiencyE B Gómez García, S R Poort, J Stibbe, et al.
Gut|July 1, 1994
Budd-Chiari syndrome in a young patient with anticardiolipin antibodies: need for prolonged anticoagulant treatmentR J Ouwendijk, J C Koster, J H Wilson, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Thrombosis and Haemostasis|February 1, 1996
Phenotyping and genotyping of coagulation factor V LeidenH Engel, L Zwang, H H van Vliet, et al.
The Netherlands Journal of Medicine|March 1, 1995
Heparin-induced thrombocytopenia and thrombosis: a potential fatal complication in a routine treatmentD M Boon, M C Kappers-Klunne, J J Michiels, et al.
Lancet (London, England)|November 5, 1994
Heparin-induced thrombocytopenia and antithrombotic therapyD M Boon, J J Michiels, J Stibbe, et al.
Nederlands Tijdschrift Voor Geneeskunde|April 16, 1994
[The HITT syndrome: thrombocytopenia and thrombosis induced by heparin as cause of paradoxically-occurring thromboembolisms]D M Boon, M C Kappers-Klunne, J J Michiels, et al.
Thrombosis Et Diathesis Haemorrhagica|September 30, 1975
Letter: A method for assaying von Willebrand factor (ristocetin cofactor)D E Macfarlane, J Stibbe, E P Kirby, et al.
Transplantation Proceedings|October 1, 1990
Fibrinolysis in auxiliary partial liver transplantationC M Bakker, R J Porte, E A Knot, et al.
Postgraduate Medical Journal|December 1, 1994
High-dose intravenous gammaglobulin therapy for acquired von Willebrand diseaseP J Van Genderen, D N Papatsonis, J J Michiels, et al.
British Journal of Haematology|August 1, 1990
Haemophilia protects against ischaemic heart disease: a study of risk factorsF R Rosendaal, E Briët, J Stibbe, et al.
British Journal of Haematology|February 13, 2001
Two novel and one recurrent missense mutation in the factor XIII A gene in two Dutch patients with factor XIII deficiencyE B Gómez García, S R Poort, J Stibbe, et al.
Gut|July 1, 1994
Budd-Chiari syndrome in a young patient with anticardiolipin antibodies: need for prolonged anticoagulant treatmentR J Ouwendijk, J C Koster, J H Wilson, et al.
Pageof 7